Reisenauer Janani S, Puig Carlos A, Reisenauer Chris J, Allen Mark S, Bendel Emily, Cassivi Stephen D, Nichols Francis C, Shen Rob K, Wigle Dennis A, Blackmon Shanda H
Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.
Department of Radiology, Mayo Clinic, Rochester, Minnesota.
Ann Thorac Surg. 2018 Jan;105(1):254-262. doi: 10.1016/j.athoracsur.2017.07.021. Epub 2017 Nov 11.
Postoperative chylothorax can be managed by any or all of observation, parenteral nutrition, surgical duct ligation, pleurodesis, or thoracic duct embolization. The objective of this study was to determine the efficacy of standard therapies, such as surgical duct ligation and observation, compared with newer treatment methods (thoracic duct embolization).
A prospectively maintained database at a single institution was used to identify and review patients with postoperative chylothorax from 2008 to 2015.
Postoperative chylothorax occurred in 97 patients, including 54 men (56%). The median age was 61 years (range, 24 to 87 years). Thoracic duct leak followed esophagectomy in 46 patients (47%), pulmonary resection in 30 (31%), mediastinal mass resection in 7 (8%), and after other procedures in 15. Of 28 medically observed patients achieving resolution without intervention, the median peak chest tube output in 24 hours was 725 mL compared with 1,910 mL in the group that required intervention (p = 0.0001). Thoracic duct ligation was successful in 44 of 52 patients that proceeded to the operating room (85%). Of the 40 patients undergoing diagnostic lymphangiography, a leak was identified in 34 (85%), but the cisterna chyli could only be cannulated in 19 (48%) and was subsequently successful in 15 (38%).
Patients with chylous chest tube outputs of 1,100 mL or more in 24 hours postoperatively should be considered for intervention. Intention-to-treat analysis shows surgical duct ligation is more effective than thoracic duct embolization, with the ability to cannulate the cisterna chyli being the limiting factor. Lymphangiography may help determine which patients are better treated with ligation or embolization.
术后乳糜胸可通过观察、肠外营养、手术结扎胸导管、胸膜固定术或胸导管栓塞术等任何一种或全部方法进行处理。本研究的目的是确定手术结扎胸导管和观察等标准治疗方法与较新的治疗方法(胸导管栓塞术)相比的疗效。
使用单一机构前瞻性维护的数据库来识别和回顾2008年至2015年的术后乳糜胸患者。
97例患者发生术后乳糜胸,其中男性54例(56%)。中位年龄为61岁(范围24至87岁)。46例(47%)患者在食管切除术后发生胸导管漏,30例(31%)在肺切除术后发生,7例(8%)在纵隔肿物切除术后发生,15例在其他手术后发生。在28例未经干预而病情缓解的观察治疗患者中,24小时胸腔闭式引流管引流量峰值的中位数为725 mL,而在需要干预的组中为1910 mL(p = 0.0001)。52例接受手术的患者中,44例(85%)胸导管结扎成功。在40例行诊断性淋巴管造影的患者中,34例(85%)发现有漏口,但仅19例(48%)能成功插管至乳糜池,随后15例(38%)成功。
术后24小时胸腔闭式引流管乳糜引流量达1100 mL或更多的患者应考虑进行干预。意向性分析表明,手术结扎胸导管比胸导管栓塞术更有效,能否成功插管至乳糜池是限制因素。淋巴管造影可能有助于确定哪些患者采用结扎术或栓塞术治疗效果更佳。